David, can you pull a handful of stocks
of your valuation list which have anti-
angiogenesis compounds. I know there
must be a few less well-known companies,
which are also bargains in which to invest.
We have seen good discussion of Celgene
by the biotech guys...I believe ImClone
has a candidate, preclinical, and then
there is angiopoietins/TIE receptor but
I have read those posts and it is of course
over my head. Cheap biotech stocks all over,
but cant own them all!
Also there are crazy gambles like Magainin,
of which I was again reminded on another
thread--maybe that one has bottomed out too,
but I can not say anything at all about any
of the science.
Was disappointed by the Waldholz interview,
small/micro biotech is really ignored, MW did
not do much to get anybody excited, he must
be trading internuts with the rest of them... |
